Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries.
C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.
Some six months after establishing itself as an independent entity, the company plans to roughly double its protein biomarker libraries by the end of the year.
Among the launches at the organization's annual meeting this week in Taipei were a personalized proteomics initiative and a new DIA mass spec method.
The partners will collaborate on pilot studies evaluating the Avatar system and analytics platform in the immunoprofiling of cancer patients.
The Japan Times says regulations are needed to oversee human genome-editing research.
In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.
At Wired, a science journalist discusses her decision not to undergo BRCA testing.
In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.